- Trials with a EudraCT protocol (13)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
13 result(s) found for: Dental Prophylaxis.
Displaying page 1 of 1.
EudraCT Number: 2020-004564-26 | Sponsor Protocol Number: BAS20 | Start Date*: 2021-09-20 | |||||||||||
Sponsor Name:Karolinska Institute | |||||||||||||
Full Title: Role of antibiotics in conjunction with oral bone augmentation procedures (BAS20) | |||||||||||||
Medical condition: Patients requiring bone augmentation procedure prior to, or in conjunction to installation of dental implants. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001068-39 | Sponsor Protocol Number: ECPAF11/16 | Start Date*: 2018-07-24 |
Sponsor Name:OMEQUI | ||
Full Title: Changes in the bone morphology of the post-extraction socket, preserved with platelet-rich fibrin and leukocytes (L-PRF) versus Conventional treatment | ||
Medical condition: Regenerative potential of L-PRF | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001811-56 | Sponsor Protocol Number: Syst.Antibiotics&GBR | Start Date*: 2014-09-26 |
Sponsor Name:Medizinische Universität Graz, Universitätsklinik für Zahn-, Mund- und Kieferheilkunde | ||
Full Title: The effect of systemic antibiotics on clinical and patient-centered outcomes of implant therapy and simultaneous guided bone regeneration. A randomised controlled clinical trial. | ||
Medical condition: | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-002236-87 | Sponsor Protocol Number: RH01561 | Start Date*: 2012-08-16 | ||||||||||||||||
Sponsor Name:GlaxoSmithKline Consumer Healthcare | ||||||||||||||||||
Full Title: Clinical Study to Evaluate the Efficacy of Chlorhexidine Mouthwashes | ||||||||||||||||||
Medical condition: Gingival bleeding and gingivitis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-002418-11 | Sponsor Protocol Number: RH01913 | Start Date*: 2013-08-12 | ||||||||||||||||
Sponsor Name:GlaxoSmithKline Consumer Healthcare | ||||||||||||||||||
Full Title: A study to evaluate the effect of a 67% Sodium Bicarbonate containing toothpaste on Chlorhexidine Digluconate tooth staining | ||||||||||||||||||
Medical condition: Tooth discolouration (a labelled undesirable effect of Corsodyl 0.2% mouthwash) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: Removed from public view |
EudraCT Number: 2020-005092-13 | Sponsor Protocol Number: MO42623 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||
Full Title: A MULTICENTER, OPEN-LABEL PHASE IV STUDY TO EVALUATE OVERALL HEALTH, PHYSICAL ACTIVITY, AND JOINT OUTCOMES, IN PARTICIPANTS AGED ≥ 13 AND < 70 YEARS WITH SEVERE OR MODERATE HEMOPHILIA A WITHOUT FVI... | |||||||||||||
Medical condition: Severe or Moderate Hemophilia A | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Prematurely Ended) DE (Ongoing) ES (Ongoing) IT (Ongoing) HU (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005916-23 | Sponsor Protocol Number: ML39791 | Start Date*: 2020-12-18 | ||||||||||||||||
Sponsor Name:Genentech, Inc. | ||||||||||||||||||
Full Title: A Phase IV, Multicenter, Single-Arm, Open-Label Study of Emicizumab Prophylaxis in Patients With Hemophilia A With or Without Inhibitors Undergoing Minor Surgical Procedures | ||||||||||||||||||
Medical condition: Hemophilia A with or without inhibitors | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-006006-27 | Sponsor Protocol Number: 0869-219 | Start Date*: 2012-11-05 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc | |||||||||||||
Full Title: A Phase IIb, Partially-Blinded, Randomized, Active Comparator-Controlled Study to Evaluate the Pharmacokinetics/Pharmacodynamics, Safety, and Tolerability of Aprepitant in Pediatric Patients for th... | |||||||||||||
Medical condition: Post Operative Nausea and Vomiting in surgical patients | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) ES (Completed) CZ (Completed) IT (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001040-23 | Sponsor Protocol Number: A6431085 | Start Date*: 2005-06-08 | |||||||||||
Sponsor Name:Pfizer Consumer Healthcare, Pfizer Health AB | |||||||||||||
Full Title: AN EVALUATOR-BLINDED, OPEN, RANDOMIZED, PARALLEL CONTROLLED STUDY ON NICORETTE® FRESHMINT GUM VS NICORETTE® MICROTAB IN HEALTHY SMOKERS MOTIVATED TO QUIT SMOKING AND WITH VISIBLE STAINING OF TEETH | |||||||||||||
Medical condition: Nicotine dependance. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001359-11 | Sponsor Protocol Number: 261204 | Start Date*: 2013-12-17 | |||||||||||
Sponsor Name:Baxalta Innovations GmbH | |||||||||||||
Full Title: A Phase 3, Multi-Center, Open Label Study of Efficacy and Safety of PEGylated rFVIII (BAX 855) in Previously Treated Patients With Severe Hemophilia A Undergoing Surgical or Other Invasive Procedures | |||||||||||||
Medical condition: Severe hemophilia A (FVIII<1%) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) BE (Completed) LT (Completed) BG (Completed) ES (Completed) DE (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000618-23 | Sponsor Protocol Number: ORN-01 | Start Date*: 2015-05-05 | ||||||||||||||||
Sponsor Name:Västra Götalandsregionen/NÄL | ||||||||||||||||||
Full Title: Treatment of osteoradionecrosis (ORN) with pentoxifylline and α-tocopherol (PENTO) | ||||||||||||||||||
Medical condition: Osteoradionecrosis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002505-35 | Sponsor Protocol Number: ABCSG_50 | Start Date*: 2018-06-25 | |||||||||||||||||||||
Sponsor Name:ABCSG (Austrian Breast & Colorectal Cancer Study Group) | |||||||||||||||||||||||
Full Title: BRCA-P: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, International Phase 3 Study to determine the Preventive Effect of Denosumab on Breast Cancer in Women carrying a BRCA1 Germline... | |||||||||||||||||||||||
Medical condition: Prevention of breast cancer in women with a BRCA1 germline mutation | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||
Trial protocol: AT (Ongoing) ES (Ongoing) DE (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001631-46 | Sponsor Protocol Number: NL65876.078.18 | Start Date*: 2019-02-14 | |||||||||||
Sponsor Name:Erasmus University Medical Center | |||||||||||||
Full Title: Implementation of pharmacokinetic-guided dosing of DDAVP and VWF-containing concentrates in von Willebrand disease | |||||||||||||
Medical condition: Von Willebrand disease | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.